Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_1
10
83%
Ph phase_2
1
8%

Phase Distribution

10

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
10(83.3%)
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 110 (83.3%)
Phase 21 (8.3%)
N/A1 (8.3%)

Trials by Status

active_not_recruiting18%
completed867%
unknown325%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12